MarketPeel
Pricing
…
EH

Eric A. Hughes

TEVA
SEE "REMARKS" · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001938678
FILING MIX · LIFETIME44%/56%
BUYS
20
SELLS
25
TOTAL VALUE
$7.49M
COMPANIES
2
ACTIVE SINCE
Aug 2022
HOLDINGS NOW
186,255
AVG SELL PX
$20.90
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 17 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Eric A. Hughes, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+53.85%+0.54%-1.35%+1.89%+0.11%—
14d13+38.46%+2.10%-0.94%+3.04%+2.65%—
30d13+61.54%-0.29%-2.63%+2.34%-0.13%—
60d13+0.00%+8.28%+2.19%+6.08%+3.90%—
90d13+0.00%+10.73%+3.75%+7.59%+6.95%—
180d13(4 pending)+11.11%+31.96%+11.38%+20.57%+7.78%—
1y13(4 pending)+22.22%+73.02%+18.35%+54.67%+84.86%—
2y13(9 pending)+0.00%+108.43%+40.06%+68.36%+59.91%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TEVA · 160,455 shares · as of Aug 3, 2026
052,743105,485158,228210,9702023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 20 buys / 25 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
52,744——160,455Aug 3, 2026Aug 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
25,578$34.88$892.1K134,877Aug 3, 2026Aug 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
52,744——0Aug 3, 2026Aug 5, 2026 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,800——25,800Jun 11, 2026Jun 12, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
19,654——117,244Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
19,654——58,962Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
9,533$31.67$301.9K107,711Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
11,277$32.46$366.1K97,590Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
23,251——108,867Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
23,251——46,503Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
50,643——50,643Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
24,900——24,900Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
141,478——154,301Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
24,900——24,901Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
68,685$32.36$2.22M85,616Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
12,077$32.36$390.8K12,823Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
141,478——0Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
141,478——141,478Jan 27, 2026Jan 29, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
52,742$15.16$799.4K0Aug 1, 2025Aug 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
52,742——52,744Aug 1, 2025Aug 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
52,742——52,742Aug 1, 2025Aug 5, 2025 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,700——30,700Jun 13, 2025Jun 16, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
78,616——78,616Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
8,077$15.91$128.5K0Mar 5, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
5,174$15.56$80.5K0Mar 4, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
15,174$15.73$238.8K8,077Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
23,251——23,251Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
23,251——69,754Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
24,900——49,801Mar 3, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
19,726$16.19$319.3K5,174Mar 3, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
24,900——24,900Mar 3, 2025Mar 5, 2025 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
44,200——44,200Dec 11, 2024Dec 13, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
45,060$17.38$783.0K0Aug 9, 2024Aug 13, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
52,742——105,486Aug 1, 2024Aug 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
52,742——69,597Aug 1, 2024Aug 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
24,537$17.25$423.3K45,060Aug 1, 2024Aug 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
93,005——93,005Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
8,045$13.34$107.3K16,855Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
24,900——74,701Mar 3, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
24,900——24,900Mar 3, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
See "Remarks"
52,742——52,742Aug 1, 2023Aug 3, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
52,742$8.30$437.7K0Aug 1, 2023Aug 3, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
See "Remarks"
52,742——158,228Aug 1, 2023Aug 3, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
99,601——99,601Mar 3, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
210,970——210,970Aug 1, 2022Aug 3, 2022 ↗View →
Other insiders · TEVA
Loading peer insiders…
About this filer
CIK 0001938678
ROLE
See "Remarks"
PRIMARY
TEVA
COMPANIES
2
ACTIVE SINCE
Aug 2022
MARKETPEEL · /INSIDER/0001938678DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback